XML 25 R47.htm IDEA: XBRL DOCUMENT
v2.4.0.6

INTANGIBLE ASSETS PATENTS (Details) (USD $) | Dec. 31, 2011 | Sep. 29, 2009 | Sep. 17, 2009
--- | --- | --- | ---
Merger Agreement common stock issued |  |  | 4,500,000
Pharma Tech to sell a minimum of the product each year |  |  | $ 500,000
BioPharma transaction intangible asset recorded in the amount |  |  | 4,187,815
Common share issued on the date of acquisition par value per share |  |  | $ 0.93
Agreement resulting in an impairment | 3,208,372 |  |
Accumulated amortization as of | 418,782 |  |
Intangible asset, net of acumulated amorization as of | 37,185 |  |
Balance of the intangible asset amortized | 27,044 |  |
Common stock issued for patent |  | 500,000 |
Legal fees Payable amount |  | 47,595 |
Patent recorded an intangible asset |  | 462,715 |
Shares issued per share value |  | $ 0.93 |
Assumed liability |  | $ 47,595 |

X
- Definition Carrying amount of accumulated amortization of current costs capitalized at the end of the reporting period. + References No definition available. + Details
Name: | fil_AccumulatedAmortizationAsOf
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Value of impairment of intangible asset recorded as of December 31, 2011 + References No definition available. + Details
Name: | fil_AgreementResultingInAnImpairment
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Dollar value of legal fees assumed in purchase of asset and used to determine asset value + References No definition available. + Details
Name: | fil_AssumedLiability
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. + References No definition available. + Details
Name: | fil_BalanceOfTheIntangibleAssetAmortized
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Original recorded value assigned to marketing contracts acquired as part of the BioPharma acquisition + References No definition available. + Details
Name: | fil_BioPharmaTransactionIntangibleAssetRecordedInTheAmount
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair Market Value of stock issued in purchase of asset, as determined by the purchase transaction. + References No definition available. + Details
Name: | fil_CommonShareIssuedOnTheDateOfAcquisitionParValuePerShare
Namespace Prefix: | fil_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares of common stock issued to purchase the patent + References No definition available. + Details
Name: | fil_CommonStockIssuedForPatent1
Namespace Prefix: | fil_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition This is the value of the intangible asset, net of accumulated amortization + References No definition available. + Details
Name: | fil_IntangibleAssetNetOfAcumulatedAmorizationAsOf
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Dollar value of legal fees assumed in purchase of asset and used to determine asset value. + References No definition available. + Details
Name: | fil_LegalFeesPayableAmount
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Common Stock were issued in exchange for all the outstanding common stock of BioPharma + References No definition available. + Details
Name: | fil_MergerAgreementCommonStockIssued
Namespace Prefix: | fil_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Patent recorded an intangible asset + References No definition available. + Details
Name: | fil_PatentRecordedAnIntangibleAsset
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The initial focus of the agreement was on sales of CellerateRX&#174; and required Pharma Tech to sell a minimum of the product each year of the five year agreement to maintain the exclusive right to sell the product + References No definition available. + Details
Name: | fil_PharmaTechToSellAMinimumOfTheProductEachYear
Namespace Prefix: | fil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Common stock per share value issued for patent. + References No definition available. + Details
Name: | fil_SharesIssuedPerShareValue
Namespace Prefix: | fil_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant